Jazz Pharmaceuticals (JAZZ)
(Delayed Data from NSDQ)
$110.45 USD
+0.42 (0.38%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $110.46 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 32% (79 out of 250)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.53 | 1.52 | 9.99 |
Current Quarter Estimate | 5.47 | 0.70 | 63.00 |
Year Ago Quarter Estimate | 4.84 | 0.11 | 52.25 |
Next Quarter Estimate | 6.05 | -1.97 | 66.00 |
Next Year Estimate | 21.95 | 11.25 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 6.72 | 18.30 | 15.67 |
Next Year | 12.45 | 17.00 | 11.34 |
Last 5 Years | 5.40 | 5.00 | 8.10 |
Next 5 Years | 5.00 | 19.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 6.19 | 2.46 |
Price/Book (MRQ) | 1.81 | 1.48 |
Price/Cash Flow (MRFY) | 3.97 | 8.62 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 10.10% | -3.37% |
Return on Equity (TTM) | 28.65% | -75.61% |
Debt to Equity (MRQ) | NA | 0.55 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.